The rise and rise of Patanjali is leading to downgrade of Dabur, Nestle, Colgate Palmolive
Advertisement
Baba Ramdev’s Patanjali’s phenomenal rise is posing some serious troubles for FMCG giants like Dabur, Nestle, Emami, etc.
The shares of these FMCG giants, which have dominated the industry, had expensive valuations and this can lead of downgrade of earnings.
Nestle is trading at 88 times to its 12-month earnings; whereas Emami is around 44-times.
Meanwhile, Dabur is trading at about 40 times andColgate-Palmolive 's valuations are at 39.5 times to its one-year earnings.
Patanjali products, which range from soap to medicines, have become an instant hit among consumers.
Patanjali clocked revenues of about Rs 450 crore in fiscal year 2012 and shares of Colgate-Palmolive declined 21.7% in last one year.
Aditya Mathur, research analyst at Citi, told ET, “There are competitive pressures for the incumbents due to Patanjali. The pricing of products might be an issue in categories such as health supplements, including honey, chyawanprash, and also certain premium segments like hand and face wash, and others, where the price value equation could work in Patanjali's favour."
Advertisement
The shares of these FMCG giants, which have dominated the industry, had expensive valuations and this can lead of downgrade of earnings.
Meanwhile, Dabur is trading at about 40 times and
Advertisement
Aditya Mathur, research analyst at Citi, told ET, “There are competitive pressures for the incumbents due to Patanjali. The pricing of products might be an issue in categories such as health supplements, including honey, chyawanprash, and also certain premium segments like hand and face wash, and others, where the price value equation could work in Patanjali's favour."
Advertisement
- I spent $2,000 for 7 nights in a 179-square-foot room on one of the world's largest cruise ships. Take a look inside my cabin.
- Saudi Arabia wants China to help fund its struggling $500 billion Neom megaproject. Investors may not be too excited.
- Colon cancer rates are rising in young people. If you have two symptoms you should get a colonoscopy, a GI oncologist says.
- Audi to hike vehicle prices by up to 2% from June
- Kotak Mahindra Bank shares tank 13%; mcap erodes by ₹37,721 crore post RBI action
- Rupee falls 6 paise to 83.39 against US dollar in early trade
- Markets decline in early trade; Kotak Mahindra Bank tanks over 12%
- An Ambani disruption in OTT: At just ₹1 per day, you can now enjoy ad-free content on JioCinema